4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001628280-26-003418
Chief Financial Officer sold 1,882 shares at $18.15 ($34,162)
- Chief Financial Officer acquired 1,882 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hyep Ivan Chief Financial Officer | 2026-01-22 | Option exercise 10b5-1 | +1,882 | $3.79 | $7,132 | 147,237 | D |
| Hyep Ivan Chief Financial Officer | 2026-01-22 | Sale 10b5-1 | −1,882 | $18.15 | $34,162 | 145,355 | D |
| Derivatives | |||||||
| Hyep Ivan Chief Financial Officer | 2026-01-22 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,882 | 65,462 | D | ||
| Open-market sales · 1,882 sh · avg $18.15 · $34,162 | |||||||
Loading xslF345X05/wk-form4_1769463219.xml…